Ra Capital Management, L.P. T Scan Therapeutics, Inc. Transaction History

Ra Capital Management, L.P.

  • $4.58 Billion
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.65 - $3.58 $1.69 Million - $3.66 Million
-1,021,764 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$2.8 - $5.4 $653,948 - $1.26 Million
-233,553 Reduced 18.61%
1,021,764 $2.86 Million
Q3 2021

Nov 15, 2021
BUY
$6.17 - $13.48 $7.75 Million - $16.9 Million
1,255,317 New
1,255,317 $10.5 Million

Others Institutions Holding TCRX

# of Institutions
80
Shares Held
37.8M
Call Options Held
0
Put Options Held
0
View Full List

About TScan Therapeutics, Inc.

TCRX Quotes by TradingView
  • Ticker TCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,929,800
  • Market Cap $36.5M
  • Description
  • TScan Therapeutics, Inc., a preclinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell therapies for the treatment of patients with cancer. It is developing TSC-100 and TSC-101 for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell ...
More about TCRX
Track This Portfolio

Track Ra Capital Management, L.P. Portfolio

Follow Ra Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email